Filtered By:
Management: WHO
Vaccination: Pneomococcal Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 99 results found since Jan 2013.

Status of New Vaccine Introduction - Worldwide, 2016-2021
This report describes the status of introductions globally for eight World Health Organization (WHO)-recommended new and underutilized vaccines, comprising 10 individual vaccine antigens. By 2021, among 194 countries worldwide, 33 (17%) provided all of these 10 WHO-recommended antigens as part of their routine immunization schedules; only one low-income country had introduced all of these recommended vaccines. Universal hepatitis B birth dose; human papillomavirus vaccine; rotavirus vaccine; and diphtheria, tetanus, and pertussis-containing vaccine first booster dose have been introduced by 57%, 59%, 60%, and 72% of all co...
Source: MMWR Morb Mortal Wkl... - July 6, 2023 Category: Epidemiology Authors: Gurpreet Kaur Rebecca M Casey Jaymin C Patel Paul Bloem Jenny A Walldorf Terri B Hyde Source Type: research

Evaluation of the World Health Organization Global Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Network's Laboratory External Quality Assessment Programme, 2014-2019
Conclusion. The EQA has been an important tool in maintaining high standards of laboratory testing and building of laboratory capacity in the GISN.PMID:36748422 | DOI:10.1099/jmm.0.001644
Source: Journal of Medical Microbiology - February 7, 2023 Category: Microbiology Authors: David Litt Mary P E Slack Tomoka Nakamura Steve Gray Shila Seaton Elizabeth J Fagan Carmen Sheppard Jason M Mwenda Gloria Rey-Benito Amany Ghoniem Dovile Videbaek Emanuel Tondo Varja Grabovac Fatima Serhan Source Type: research

COVID-19 in elderly: Correlations of viral load, clinical course, laboratory parameters, among patients vaccinated with CoronaVac
This study aimed to investigate the association of viral load and laboratory parameters with the severity of the disease and vaccination status in elderly (older than 60 years old) COVID-19 patients. The age range of the patients was 61-97 years old with a mean of 71.80. Vaccinated patients had a lower viral load (P = 0.253) in nasopharyngeal swabs during breakthrough COVID-19 infection compared to unvaccinated ones and were hospitalized for a shorter period of time in hospital wards (P = 0.035). A lower number of patients were vaccinated in both moderate (n = 33, 29.20%) and severe/critical group (n = 46, 34.07%) (P = 0.4...
Source: Acta Microbiologica et Immunologica Hungarica - November 12, 2022 Category: Microbiology Authors: Sabri Engin Altintop Tugce Unalan-Altintop Mustafa Cihangiroglu Pelin Onarer Fikriye Milletli-Sezgin Melih Gozukara Bilge Gozukara Erman Zengin Source Type: research